Business Daily meets: US healthcare CEO Judy Faulkner

Business Daily meets: US healthcare CEO Judy ...

Up next

Germany turns to India for skilled workers

Germany is in the throes of a demographic crisis, in which there are not enough young people entering the labour market to replace those who are retiring. There is an annual net loss of 400,000 to the workforce and the shortage is particularly acute in many of the traditional cra ...  Show more

China’s new economic reality

We look at what China’s latest “Two Sessions” reveal about the direction of the world’s second-largest economy. With Beijing setting its lowest GDP growth target since 1991, the focus appears to be shifting from rapid expansion to stability in an increasingly uncertain global eco ...  Show more

Recommended Episodes

002: Aidence and the future of radiology, with Dr Lizzie Barclay 🤖🇳🇱
The Healthtech VC

In this week’s episode of The Healthtech VC, Dr. Fiona Pathiraja meets fellow former radiologist Dr Lizzie Barclay, who is now medical director of Aidence, an Amsterdam based start-up creating innovative AI that helps radiologists in the diagnosis of lung cancer.

Lizz ...

  Show more

Kate Cronin (Moderna) | Pioneering Biotech Company and their Software of Life
The CMO Podcast

Fall means it's time for your annual flu and Covid shots! So, this week on The CMO Podcast, Jim welcomes Kate Cronin, the Chief Brand Officer for Moderna, the 14-year-old pioneering biotech company. Moderna achieved nearly instant awareness and fame in 2020, when it received ...

  Show more

Bain Capital, David Humphrey and Devin O’Reilly – Partnering, Merging, and Growing at Zelis (S1, EP.6)
Private Equity Deals with Capital Allocators

Dave is the Co-Head of Bain Capital’s North America Private Equity business and a Managing Director in the TMT vertical. Devin is the Head of the firm’s North America Healthcare vertical. Bain Capital manages $180 billion, about half of which is in private equity. Its CEO, John C ...  Show more

Roche CEO: Future of cancer treatment, AI in Medicine and Trial Challenges
In Good Company with Nicolai Tangen

What’s next for cancer treatment and personalized medicine? How is AI reshaping the future of drug discovery? And can Europe keep pace with China’s rapid rise in health care innovation? In this episode, Nicolai welcomes Thomas Schinecker, CEO of Roche, one of the world’s large ...

  Show more